Clinical practice (London, England)最新文献

{"title":"Identification of 2 large size HCC phenotypes, with and without associated inflammation.","authors":"Brian I Carr,&nbsp;Harika Gozukara Bag,&nbsp;Hikmet Akkiz,&nbsp;Ümit Karaoğullarından,&nbsp;Volkan Ince,&nbsp;Burak Isik,&nbsp;Sezai Yilmaz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Large HCCs can often be associated with low levels of cirrhosis. However, inflammation is also regarded as a driver of HCC growth.</p><p><strong>Objectives: </strong>To compare patients with large >5 cm HCCs having high versus low serum inflammation parameters.</p><p><strong>Materials and methods: </strong>A Turkish patient HCC dataset with known survivals was retrospectively analyzed after dichotomization according to several clinical inflammation markers.</p><p><strong>Results: </strong>Amongst several parameters examined, only AST levels were significantly associated with elevated AFP levels and increased percent PVT and tumor multifocality. The dichotomization of the cohort according to high or low AST levels resulted in 2 subcohorts with a 5-fold difference in median survival. The 2 AST-dichotomised cohorts comprised patients with similar large-size HCCs, but which were significantly different with respect to serum AFP levels, percent PVT, and percent tumor multifocality.</p><p><strong>Conclusions: </strong>Two large-sized HCC phenotypes were identified. One had more aggressive HCC characteristics, higher inflammatory indices, and worse survival. The other had the opposite. Despite inflammation being important for the growth of some large tumors, others of a similar size likely have different growth mechanisms.</p>","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"19 4","pages":"1953-1958"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449386/pdf/nihms-1922145.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation.","authors":"Brian I Carr,&nbsp;Volkan Ince,&nbsp;Harika Gozukara Bag,&nbsp;Sertac Usta,&nbsp;Veysel Ersan,&nbsp;Burak Isik,&nbsp;Sezai Yilmaz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Inflammation and its markers are considered prognostically important for many cancers, including Hepatocellular Carcinoma (HCC). However, it is not really clear which markers are the best.</p><p><strong>Aims: </strong>To assess in a cohort of prospectively-evaluated HCC patients who were treated with liver transplant and whose survival was known, multiple commonly used inflammatory markers in relation to survival and to both clinical and tumor aggressiveness parameters.</p><p><strong>Results: </strong>Amongst 330 transplanted HCC patients, CRP was found to be the only significant inflammatory marker for survival, on multivariate Cox regression analysis. NLR, PLR, GGT, AST, ALT and the Glasgow inflammation score were also found to be significant, but on univariate analysis only. CRP was significant in patients with both small (< 5 cm) and large HCCs and in patients with elevated or low Alpha-Fetoprotein (AFP) levels. Comparison of HCC patients with high (>2.5 mg/ dL) compared low serum CRP levels showed significant differences for blood levels of NLR, LMR, Hb, total bilirubin and liver transaminases, as well as Maximum Tumor Diameter (MTD) and percent of patients with Portal Vein Thrombosis (PVT).</p><p><strong>Conclusions: </strong>Elevated serum CRP levels were associated with significantly increased MTD and percent of patients with PVT and significantly worse overall survival in HCC patients who were treated by liver transplantation.</p>","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"18 2","pages":"1626-1632"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106696/pdf/nihms-1690116.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38969176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A simple 2-parameter blood test alert for the presence of small hepatocellular carcinomas.","authors":"Brian I Carr,&nbsp;Harika Gozukara Bag,&nbsp;Volkan Ince,&nbsp;Zeki Ogut,&nbsp;Adem Tuncer,&nbsp;Sami Akbulut,&nbsp;Veysel Ersan,&nbsp;Sertac Usta,&nbsp;Burak Isik,&nbsp;Sezai Yilmaz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>The majority of HCCs present at an advanced stage in which potentially curative therapies cannot be used. Surveillance ultrasound has been found to increase the numbers of patients diagnosed with small tumors, but it is often not used. We aimed to try to identify widely-available and cheap potential serum markers for use in patients at risk for HCC.</p><p><strong>Material and methods: </strong>A comparison was made of the complete blood count and liver function tests in a group of patients (n=114) with proven small HCCs (≤ 2 cm) and patients without HCC (n=506), all of whom were treated by liver transplantation in our Liver Transplantation Institute.</p><p><strong>Results: </strong>Significant differences were found for blood levels of WBC, lymphocytes, total bilirubin and transaminases. Several 2-parameter combinations were assessed, but only the combination of total bilirubin and lymphocytes was found to be significantly different between patients with small HCCs and no HCC. Multivariate regression analysis showed significance only for total bilirubin levels and lymphocyte counts. The results were confirmed using a separate small cohort of non-transplant patients.</p><p><strong>Conclusion: </strong>The combination of elevated levels of total bilirubin and lymphocyte counts holds promise for identification of patients with chronic liver disease who are at risk for HCC.</p>","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"18 8","pages":"1804-1809"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714058/pdf/nihms-1763515.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39860507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Microscopic vascular invasion by hepatocellular carcinoma in liver transplant patients.","authors":"Brian I Carr,&nbsp;Volkan Ince,&nbsp;Harika Gozukara Bag,&nbsp;Veysel Ersan,&nbsp;Sertac Usta,&nbsp;Sezai Yilmaz","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>A characteristic of Hepatocellular Carcinoma (HCC) is to invade the portal venous system in the liver as a means of spread within the liver and systemically. The ensuing Portal Vein Thrombosis (PVT) is a poor prognosis parameter and often diagnosed radiologically pre-treatment. More limited Microvascular Portal Invasion (microPVI) is typically diagnosed on examination of tumors removed after treatment by resection or transplant. The biological characteristics and subsets of PVI are incompletely characterized.</p><p><strong>Aims: </strong>To examine HCC patients with and without microPVI to understand the clinical relationships to other tumor and clinical characteristics and to survival.</p><p><strong>Methods: </strong>A cohort of 270 liver transplant patients with HCC without macroscopic PVT that were available to us was examined. Patients with (165) and without (105) microPVI were compared for survival and clinical features.</p><p><strong>Results: </strong>The mean survival of patients with and without microPVI was significantly different: 86.6 versus 110.5 months, p=0.007.The microPVI+ patients differed from microPVI- patients in having a significantly larger number of tumor nodules, tumor size and higher serum levels of both Alpha-Fetoprotein (AFP) and almost significant for higher Gamma-Glutamyl Transpeptidase (GGT, p=0.053). Survival in microPVI+ patients related significantly to serum GGT (p=0.006) but not to AFP levels. The incidence of microPVI increased with increase in tumor size and survival decreased significantly with increase in tumor size for microPVI patients. Increase in tumor size was also associated with significantly higher serum GGT levels in patients who were microPVI+, but not in those who were microPVI. Furthermore, patients with microPVI who had prolonged survival significantly differed from those with shorter survival in respect only to tumor size and serum GGT levels.</p><p><strong>Conclusion: </strong>These findings draw attention to a group of patients with microPVI who have long survival and to the usefulness of serum GGT levels in their evaluation and prognosis.</p>","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"17 3","pages":"1497-1505"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746034/pdf/nihms-1652505.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38731604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"HCC with low- and normal-serum alpha-fetoprotein levels.","authors":"Brian I Carr,&nbsp;Hikmet Akkiz,&nbsp;Oguz Üsküdar,&nbsp;Kendal Yalçın,&nbsp;Vito Guerra,&nbsp;Sedef Kuran,&nbsp;Ümit Karaoğullarından,&nbsp;Engin Altıntaş,&nbsp;Ayşegül Özakyol,&nbsp;Salih Tokmak,&nbsp;Tuğsan Ballı,&nbsp;Mehmet Yücesoy,&nbsp;Halil İbrahim Bahçeci,&nbsp;Abdulalh Ülkü,&nbsp;Tolga Akçam,&nbsp;Kamil Yalçın Polat,&nbsp;Nazım Ekinci,&nbsp;Halis Şimşek,&nbsp;Necati Örmeci,&nbsp;Abdulalh Sonsuz,&nbsp;Mehmet Demir,&nbsp;Murat Kılıç,&nbsp;Ahmet Uygun,&nbsp;Ali Demir,&nbsp;Anıl Delik,&nbsp;Burcu Arslan,&nbsp;Figen Doran,&nbsp;Sezai Yilmaz,&nbsp;Yaman Tokat","doi":"10.4172/clinical-practice.1000393","DOIUrl":"https://doi.org/10.4172/clinical-practice.1000393","url":null,"abstract":"<p><p>A large database of 1773 HCC patients in Turkey was examined. 41.9% had alpha-fetoprotein (AFP) levels <20 IU/ml and an additional 16.123% had values between 20-100 IU/ml. This 58% of the cohort (<100 IU/ml AFP levels) was examined in detail. 66% of patients with small (<5 cm) HCCs had low AFP, compared to 49% of patients with larger (>5 cm) HCCs. The mean diameter (MTD) of larger MTD, low AFP tumors was 8.4cm. Therefore, factors other than AFP must contribute to HCC tumor growth. Larger tumors in low AFP patients had both higher platelet levels and increased PVT percent. Linear regression analysis for both MTD and multifocality showed that platelet numbers and presence of PVT were significant variables; whereas for PVT, significant variables were albumin, alkaline phosphatase and MTD. Comparisons between patients with AFP levels <20, 20-<100, 100-<1000 and >1000 IU/ml showed the most significant tumor finding was an increase in PVT percent between each group, and to a lesser extent, MTD. Thus, low- or normal-AFP HCCs constitute the majority of patients and have slightly lower MTD and much lower PVT percent than HCCs associated with elevated blood AFP levels. New, non-AFP markers are thus needed, especially for small HCCs.</p>","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"15 1","pages":"453-464"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/clinical-practice.1000393","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35945092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.","authors":"Brian I Carr,&nbsp;Hikmet Akkiz,&nbsp;Vito Guerra,&nbsp;Oguz Üsküdar,&nbsp;Sedef Kuran,&nbsp;Ümit Karaoğullarından,&nbsp;Salih Tokmak,&nbsp;Tuğsan Ballı,&nbsp;Abdulalh Ülkü,&nbsp;Tolga Akçam,&nbsp;Anıl Delik,&nbsp;Burcu Arslan,&nbsp;Figen Doran,&nbsp;Kendal Yalçın,&nbsp;Engin Altntaş,&nbsp;Ayşegül Özakyol,&nbsp;Mehmet Yücesoy,&nbsp;Halil İbrahim Bahçeci,&nbsp;Kamil Yalçın Polat,&nbsp;Nazım Ekinci,&nbsp;Halis Şimşek,&nbsp;Necat Örmeci,&nbsp;Abdulalh Sonsuz,&nbsp;Mehmet Demir,&nbsp;Murat Kılıç,&nbsp;Ahmet Uygun,&nbsp;Ali Demir,&nbsp;Sezai Yilmaz,&nbsp;Yaman Tokat","doi":"10.4172/clinical-practice.1000409","DOIUrl":"https://doi.org/10.4172/clinical-practice.1000409","url":null,"abstract":"<p><p>C-reactive protein (CRP) is a blood marker for inflammation and is an independent prognostic factor for many human cancers. Combined with albumin levels, it forms the basis of the Glasgow Index for cancer prognosis. We reviewed the literature on CRP and HCC and also evaluated blood CRP levels and combination CRP plus albumin levels in a large HCC cohort. In order to understand the prognostic significance of CRP, we retrospectively examined a large HCC cohort and examined the relationship of CRP levels to tumor parameters. We report, that CRP alone and CRP plus albumin combined as well, significantly correlated with parameters of HCC aggressiveness, such as maximum tumor dimension (MTD), portal vein thrombosis (PVT) and blood alpha-fetoprotein (AFP) levels, both as individual parameters and all parameters together (Aggressiveness Index). This extends current thinking, to suggest a possible explanation for the usefulness of blood CRP levels in HCC prognostication.</p>","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"15 Spec","pages":"625-634"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/clinical-practice.1000409","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36265267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans.","authors":"Farhad Ghanaat,&nbsp;John A Tayek","doi":"10.4172/clinical-practice.1000125","DOIUrl":"https://doi.org/10.4172/clinical-practice.1000125","url":null,"abstract":"<p><p>Well-established risk factors for aspergillosis include HIV, cancer, recent corticosteroid (prednisone) therapy, chemotherapy, or thoracic surgery. Non-established risk factors may include weight loss and a history of diabetes. Twenty-three patients without the classical risk factors for IA were identified retrospectively at Harbor UCLA Medical Center by discharge diagnosis over a 20 year period (1992-2012). None of the well-known risk factors are for Invasive Apergillious (IA). A history of weight loss was seen in 66% of the patients with IA (15 of 23). The weight loss ranged from 3.3 lbs to 43 lbs. In patients with weight loss the average loss was 22±3 lbs (mean±SEM). In this small group of patients with IA, diabetes was seen in 8 of the 23 (34%), which is significantly higher than the 19% incidence of diabetes seen in 100 patients with severe sepsis (p<0.05). Likewise, the 34% incidence of diabetes was higher than the 21% incidence reported in immunocompromised patients with invasive aspergillus (IA) infection (p<0.05). A reduced serum albumin concentration was seen in 33% of the study patients, which was less common than the 87% incidence seen in patients with severe sepsis or candidaemia (54%). Seventeen of the 23 patients had pulmonary involvement. While no one had a well-established risk factor for aspergillious, four patients had alcoholism as a potential risk factor. Eleven of the 23 (48%) died during the hospital stay despite antifungal therapy. Immunocompromised patients are known to have a mortality rate of approximately 45% for pulmonary or disseminated disease.</p><p><strong>Conclusion: </strong>The incidence of diabetes was greater than seen in immunocompromised patients and may be considered an additional risk factor for the development of aspergillois infection. In addition, a history of weight loss should increase the suspicion for the diagnosis of IA in otherwise a non-immunocompromised patient. Early recognition and treatment of aspergillosis in the non-immunocompromised patient may improve outcome. Weight loss and diabetes should be added to the list of well-known risk factors for invasive aspergillosis and its high mortality rate.</p>","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"14 5 Spec Iss","pages":"296-301"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901980/pdf/nihms935038.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10373807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Why are pediatric primary care providers reluctant to prescribe antidepressants to teens?","authors":"Ana Radovic,&nbsp;Elizabeth Miller,&nbsp;Bradley Stein","doi":"10.2217/cpr.14.30","DOIUrl":"https://doi.org/10.2217/cpr.14.30","url":null,"abstract":"","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"11 4","pages":"393-396"},"PeriodicalIF":0.0,"publicationDate":"2014-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/cpr.14.30","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32949210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Food-related parenting practices and child and adolescent weight and weight-related behaviors.","authors":"K Loth,&nbsp;J A Fulkerson,&nbsp;D Neumark-Sztainer","doi":"10.2217/cpr.14.5","DOIUrl":"https://doi.org/10.2217/cpr.14.5","url":null,"abstract":"<p><p>The prevalence of overweight and obesity in children has reached a concerning plateau in the past three decades, with overweight or obesity impacting approximately one-third of youth. Unhealthy weight-related behaviors, including dieting, unhealthy weight control practices and binge eating, are also a great public health concern for young people given both their high prevalence and harmful consequences. Food-related parenting practices, including food restriction and pressure-to-eat, have been associated with higher weight status, as well as the use of unhealthy weight-related behaviors, in children and adolescents. Physicians and other health care providers who work with families should discourage parents from using food restriction and pressure-to-eat parenting practices with their child or adolescent. Alternatively, parents should be empowered to promote healthy eating by focusing on making nutritious food items readily available within their home and modeling healthy food choices for their child or adolescent.</p>","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"11 2","pages":"207-220"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/cpr.14.5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34039629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnostic and therapeutic strategies for eosinophilic esophagitis.","authors":"Asifa K Zaidi,&nbsp;Ahad Mussarat,&nbsp;Anil Mishra","doi":"10.2217/cpr.14.31","DOIUrl":"https://doi.org/10.2217/cpr.14.31","url":null,"abstract":"<p><p>Eosinophilic esophagitis (EoE) is a recently recognized allergic disorder, characterized by eosophageal dysfunction, accumulation of ≥15 eosinophils/high-powered field, eosinophil microabssess, basal cell hyperplasia, extracellular eosinophilic granules in the esophageal epithelial mucosal biopsy and a lack of response to a 8-week proton pump inhibitor treatment. Despite the increased incidences and considerable progress made in understanding EoE pathogenesis, there are limited diagnostic and therapeutic options available for EoE. Currently, the only criterion for diagnosing EoE is repetitive esophageal endoscopic biopsies and histopathological evaluation. Antigen elimination or corticosteroid therapies are effective therapies for EoE but are expensive and have limitations, if continued in the long term. Hence, there is a great necessity for novel noninvasive diagnostic biomarkers that can easily diagnose EoE and assess effectiveness of therapy. Herein, we have provided an update on key molecules involved in the disease initiation, and progression and proposed novel noninvasive diagnostic molecules and strategies for EoE therapy.</p>","PeriodicalId":72620,"journal":{"name":"Clinical practice (London, England)","volume":"11 3","pages":"351-367"},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/cpr.14.31","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32817431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}